4CPS-144 Effectiveness and safety of induction therapy with vedolizumab in patients with intestinal inflammatory disease

BACKGROUND: Vedolizumab is a therapeutic alternative indicated in patients with moderate-severe inflammatory bowel disease (IBD) (ulcerative colitis (UC) and Crohn’s Disease (CD)) with loss of response or intolerance to first-line treatment. PURPOSE: To evaluate the effectiveness and safety of induc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Eur J Hosp Pharm
Hauptverfasser: Muñoz, C Gallego, Candel, M Gil, Navalón, C Iniesta, Requejo, C Caballero, Candela, M Onteniente, Valverde, I Salar
Format: Artigo
Sprache:Inglês
Veröffentlicht: BMJ Group 2018
Schlagworte:
Section 4: Clinical pharmacy services
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7535490/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.235
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge